Study examining the PROMUS Element everolimus-eluting stent in multi-center Coronary Intervention of complex Arterial Lesion Subsets
Phase of Trial: Phase III
Latest Information Update: 27 Feb 2017
Price : $35 *
At a glance
- Drugs Everolimus (Primary)
- Indications Acute coronary syndromes; Angina pectoris; Coronary artery disease; Ischaemic heart disorders
- Focus Therapeutic Use
- Acronyms SPECIALIST
- 29 Aug 2012 New source identified and integrated (ClinicalTrials.gov: US National Institutes of Health, NCT01670318).
- 21 Aug 2012 Status changed from not yet recruiting to recruiting.
- 16 Aug 2012 New trial record